J Badurski

2.7k total citations · 1 hit paper
34 papers, 2.0k citations indexed

About

J Badurski is a scholar working on Orthopedics and Sports Medicine, Surgery and Molecular Biology. According to data from OpenAlex, J Badurski has authored 34 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Orthopedics and Sports Medicine, 14 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in J Badurski's work include Bone health and osteoporosis research (16 papers), Bone Metabolism and Diseases (9 papers) and Hip and Femur Fractures (7 papers). J Badurski is often cited by papers focused on Bone health and osteoporosis research (16 papers), Bone Metabolism and Diseases (9 papers) and Hip and Femur Fractures (7 papers). J Badurski collaborates with scholars based in France, Belgium and Poland. J Badurski's co-authors include Christian Roux, Harry K. Genant, S. Ortolani, Á. Balogh, Jean‐Yves Reginster, Jorge B. Cannata‐Andía, S. Pors-Nielsen, Ego Seeman, René Rizzoli and Tim D. Spector and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of the Rheumatic Diseases.

In The Last Decade

J Badurski

31 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis

2004 1.2k citations Pierre J. Meunier, Christian Roux et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Badurski France	13	1.2k	798	733	548	325	34	2.0k
J.-P. Devogelaer Belgium	24	1.6k 1.3×	1.1k 1.3×	792 1.1×	603 1.1×	369 1.1×	48	2.6k
G. Gutierrez United States	12	451 0.4×	563 0.7×	800 1.1×	687 1.3×	200 0.6×	21	2.0k
Chui Kin Yuen Canada	18	1.7k 1.4×	1.3k 1.7×	972 1.3×	623 1.1×	201 0.6×	24	2.6k
S. Pors-Nielsen Belgium	6	1.2k 0.9×	793 1.0×	663 0.9×	398 0.7×	67 0.2×	10	1.6k
David M. Slovik United States	19	1.2k 1.0×	889 1.1×	642 0.9×	246 0.4×	124 0.4×	24	2.2k
Ryota Teshima Japan	28	768 0.6×	232 0.3×	340 0.5×	1.3k 2.4×	558 1.7×	109	2.4k
A. J. Darby United Kingdom	19	451 0.4×	336 0.4×	314 0.4×	440 0.8×	543 1.7×	37	1.7k
Elena Tsourdi Germany	25	867 0.7×	896 1.1×	709 1.0×	367 0.7×	121 0.4×	87	2.2k
Lamya Karim United States	17	730 0.6×	227 0.3×	431 0.6×	280 0.5×	156 0.5×	27	1.4k
B. Krempien Germany	24	350 0.3×	456 0.6×	355 0.5×	405 0.7×	176 0.5×	116	1.6k

Countries citing papers authored by J Badurski

Since Specialization

Citations

This map shows the geographic impact of J Badurski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Badurski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Badurski more than expected).

Fields of papers citing papers by J Badurski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Badurski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Badurski. The network helps show where J Badurski may publish in the future.

Co-authorship network of co-authors of J Badurski

This figure shows the co-authorship network connecting the top 25 collaborators of J Badurski. A scholar is included among the top collaborators of J Badurski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Badurski. J Badurski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marcinowska-Suchowierska, Ewa, Piotr Głuszko, J Badurski, et al.. (2015). Treatment of osteoporosis in Poland – availability and reasons for lack of implementation. Postępy Nauk Medycznych. 2 indexed citations

Ivergård, M, A Svedbom, E Hernlund, et al.. (2013). Epidemiology and Economic Burden of Osteoporosis in Poland. Archives of Osteoporosis. 8.

Reginster, Jean‐Yves, J Badurski, Nicholas Bellamy, et al.. (2012). Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Annals of the Rheumatic Diseases. 72(2). 179–186. 228 indexed citations

Reginster, Jean‐Yves, R. Chapurlat, H K Genant, et al.. (2011). EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL TRIAL. Osteoporosis International. 22. 1 indexed citations

Marcinowska-Suchowierska, Ewa, E. J. Czerwiński, J Badurski, Magdalena Walicka, & Marek Tałałaj. (2011). Oateoporosis – diagnostic and treatment in elderly patients. Postępy Nauk Medycznych. 47(11-12). 1024–30. 2 indexed citations

Goemaere, Stefan, J.-P. Devogelaer, C.L. Benhamou, et al.. (2011). Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis. Osteoporosis International. 23(3). 1115–1122. 76 indexed citations

Cardiel, Mario H., Paul P. Tak, W. Bensen, et al.. (2010). A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis. Arthritis Research & Therapy. 12(5). R192–R192. 21 indexed citations

Meunier, Pierre J., Christian Roux, S. Ortolani, et al.. (2009). Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporosis International. 20(10). 1663–1673. 143 indexed citations

Badurski, J, et al.. (2008). Osteoarthrology Bialystok osteoporosis study-2: epidemiology of osteoporotic fractures and 10 year fracture risk assessment in population of women in Bialystok region by FRAX™ – WHO algorithm. Reumatologia/Rheumatology. 46(2). 72–79. 3 indexed citations

10.

Badurski, J, E. J. Czerwiński, & Ewa Marcinowska-Suchowierska. (2008). Osteoporosis – fracture risk estimation Status Quo Arte Anno 2007/2008: Review of positions of World Health Organisation (WHO), European Medicine Agency (EMEA), European Society Of Clinical And Economic Aspects Of Osteoporosis And Osteoartritis (ESEAO), International Osteoporosis Foundation (IOF), Polish Foundation Of Osteoporosis (PFO) and Polish Osteoartrology Society (PTOA). Postępy Nauk Medycznych. 1 indexed citations

11.

Marquis, Patrick, Camille Roux, Díaz Curiel M, et al.. (2007). LONG-TERM BENEFICIAL EFFECTS OF STRONTIUM RANELATE ON THEQUALITY OF LIFE IN PATIENTS WITH VERTEBRAL OSTEOPOROSIS (SOTI STUDY). SHILAP Revista de lepidopterología. 10(2). 26–27. 7 indexed citations

12.

Marquis, Patrick, Christian Roux, Christine de la Loge, et al.. (2007). Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteoporosis International. 19(4). 503–510. 39 indexed citations

13.

Meunier, Pierre J., Christian Roux, Ego Seeman, et al.. (2004). The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women With Postmenopausal Osteoporosis. Obstetrical & Gynecological Survey. 59(7). 526–527. 51 indexed citations

14.

Meunier, Pierre J., Christian Roux, Ego Seeman, et al.. (2004). The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis. New England Journal of Medicine. 350(5). 459–468. 1173 indexed citations breakdown →

15.

Reginster, Jean‐Yves, R. Rizzoli, Á. Balogh, et al.. (2003). Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women without prevalent vertebral fracture. Open Repository and Bibliography (University of Liège). 2 indexed citations

16.

Reginster, Jean‐Yves, T. D. Spector, J Badurski, et al.. (2002). A short-term run-in study can significantly contribute to increasing the quality of long-term osteoporosis trials. The strontium ranelate phase 3 program. Open Repository and Bibliography (University of Liège). 13 indexed citations

17.

Reginster, Jean‐Yves, Tim Spector, J Badurski, et al.. (2002). Optimizing patient adherence and persistence in strontium ranelate phase 3 program using a short term run-in study. Open Repository and Bibliography (University of Liège). 1 indexed citations

18.

Meunier, Pierre J., C. Roux, S. Ortolani, et al.. (2002). Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis.. Osteoporosis International. 13(6). 521–522. 29 indexed citations

19.

Badurski, J, et al.. (1995). [Comparative analysis of three treatment regimens for treating gonarthritis with calcitonin, naproxen and flavonoids based on EULAR criteria and visual analogue scale (VAS)].. PubMed. 50(44-47). 37–40. 12 indexed citations

20.

Badurski, J, et al.. (1991). Chondroprotective action of salmon calcitonin in experimental arthropathies. Calcified Tissue International. 49(1). 27–34. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact